Literature DB >> 32500132

Phosphoinositide 3-kinase γ deficiency attenuates kidney injury and fibrosis in angiotensin II-induced hypertension.

Changlong An1, Jia Wen1, Zhaoyong Hu2, William E Mitch2, Yanlin Wang1,3,4,5.   

Abstract

BACKGROUND: We have shown that the CXCL16/CXCR6 axis plays a critical role in recruiting inflammatory cells and bone marrow-derived fibroblasts into the kidney leading to renal injury and fibrosis. However, the underlying signaling mechanisms are not known.
METHODS: In the present study, we examined the role of phosphoinositide-3 kinase γ (PI3Kγ) signaling in the recruitment of inflammatory cells and bone marrow-derived fibroblasts into the kidney and development of renal injury and fibrosis in an experimental model of hypertension induced by angiotensin II.
RESULTS: Blood pressure was comparable between wild-type (WT) and PI3Kγ knockout (KO) mice at baseline. Angiotensin II treatment led to an increase in blood pressure that was similar between WT and PI3Kγ KO mice. Compared with WT mice, PI3Kγ KO mice were protected from angiotensin II-induced renal dysfunction and injury and developed less proteinuria. PI3Kγ deficiency suppressed bone marrow-derived fibroblast accumulation and myofibroblast formation in the kidney and inhibited total collagen deposition and extracellular matrix protein production in the kidney in response to angiotensin II. PI3Kγ deficiency inhibited the infiltration of F4/80+ macrophages and CD3+ T cells into the kidney and reduced gene expression levels of pro-inflammatory cytokines in the kidney following angiotensin II treatment. Finally, inhibition of PI3Kγ suppressed CXCL16-induced monocyte migration in vitro.
CONCLUSION: These results indicate that PI3Kγ mediates the influx of macrophages, T cells and bone marrow-derived fibroblasts into the kidney resulting in kidney injury and fibrosis. Published by Oxford University Press on behalf of ERA-EDTA 2020. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  angiotensin II; cell signaling; chemokines; inflammation; kidney fibrosis

Mesh:

Substances:

Year:  2020        PMID: 32500132      PMCID: PMC7778344          DOI: 10.1093/ndt/gfaa062

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  39 in total

1.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

Authors:  T Sasaki; J Irie-Sasaki; R G Jones; A J Oliveira-dos-Santos; W L Stanford; B Bolon; A Wakeham; A Itie; D Bouchard; I Kozieradzki; N Joza; T W Mak; P S Ohashi; A Suzuki; J M Penninger
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

2.  CXCL16 regulates renal injury and fibrosis in experimental renal artery stenosis.

Authors:  Zhiheng Ma; Xiaogao Jin; Liqun He; Yanlin Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-08-05       Impact factor: 4.733

3.  CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.

Authors:  Jing Xu; Song-Chang Lin; Jiyuan Chen; Yuanxin Miao; George E Taffet; Mark L Entman; Yanlin Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-13       Impact factor: 4.733

Review 4.  Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases.

Authors:  Marta Ruiz-Ortega; Mónica Rupérez; Vanesa Esteban; Juan Rodríguez-Vita; Elsa Sánchez-López; Giselle Carvajal; Jesús Egido
Journal:  Nephrol Dial Transplant       Date:  2005-11-09       Impact factor: 5.992

5.  Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Authors:  Montserrat Camps; Thomas Rückle; Hong Ji; Vittoria Ardissone; Felix Rintelen; Jeffrey Shaw; Chiara Ferrandi; Christian Chabert; Corine Gillieron; Bernard Françon; Thierry Martin; Denise Gretener; Dominique Perrin; Didier Leroy; Pierre-Alain Vitte; Emilio Hirsch; Matthias P Wymann; Rocco Cirillo; Matthias K Schwarz; Christian Rommel
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

Review 6.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 7.  The PI3K/AKT Pathway and Renal Cell Carcinoma.

Authors:  Huifang Guo; Peter German; Shanshan Bai; Sean Barnes; Wei Guo; Xiangjie Qi; Hongxiang Lou; Jiyong Liang; Eric Jonasch; Gordon B Mills; Zhiyong Ding
Journal:  J Genet Genomics       Date:  2015-03-19       Impact factor: 4.275

8.  Effect of interleukin 6 deficiency on renal interstitial fibrosis.

Authors:  Jun Yang; Jiyuan Chen; Jingyin Yan; Liping Zhang; Gang Chen; Liqun He; Yanlin Wang
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

9.  Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction.

Authors:  Tomasz J Guzik; Nyssa E Hoch; Kathryn A Brown; Louise A McCann; Ayaz Rahman; Sergey Dikalov; Jorg Goronzy; Cornelia Weyand; David G Harrison
Journal:  J Exp Med       Date:  2007-09-17       Impact factor: 14.307

10.  CCR2 regulates the uptake of bone marrow-derived fibroblasts in renal fibrosis.

Authors:  Yunfeng Xia; Mark L Entman; Yanlin Wang
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

View more
  6 in total

1.  Myeloid PTEN deficiency aggravates renal inflammation and fibrosis in angiotensin II-induced hypertension.

Authors:  Changlong An; Baihai Jiao; Hao Du; Melanie Tran; Dong Zhou; Yanlin Wang
Journal:  J Cell Physiol       Date:  2021-09-13       Impact factor: 6.384

2.  Transcriptional profile changes after treatment of ischemia reperfusion injury-induced kidney fibrosis with 18β-glycyrrhetinic acid.

Authors:  Yamei Jiang; Chengzhe Cai; Pingbao Zhang; Yongsheng Luo; Jingjing Guo; Jiawei Li; Ruiming Rong; Yi Zhang; Tongyu Zhu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis.

Authors:  Baihai Jiao; Changlong An; Melanie Tran; Hao Du; Penghua Wang; Dong Zhou; Yanlin Wang
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 8.786

4.  STAT6 Deficiency Attenuates Myeloid Fibroblast Activation and Macrophage Polarization in Experimental Folic Acid Nephropathy.

Authors:  Baihai Jiao; Changlong An; Hao Du; Melanie Tran; Penghua Wang; Dong Zhou; Yanlin Wang
Journal:  Cells       Date:  2021-11-06       Impact factor: 6.600

5.  Phosphoinositide 3 Kinase γ Plays a Critical Role in Acute Kidney Injury.

Authors:  Xiaogao Jin; Qinjun Chu; Liwei Sun; Melanie Tran; Yanlin Wang
Journal:  Cells       Date:  2022-02-23       Impact factor: 7.666

6.  Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice.

Authors:  Roberto Palacios-Ramirez; Ixchel Lima-Posada; Benjamin Bonnard; Marie Genty; Amaya Fernandez-Celis; Judith Hartleib-Geschwindner; Fabienne Foufelle; Natalia Lopez-Andres; Krister Bamberg; Frederic Jaisser
Journal:  Front Physiol       Date:  2022-04-07       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.